EVIDENCE FOR POLYMORPHIC OXIDATION OF SPARTEINE IN JAPANESE SUBJECTS

被引：58
作者：
ISHIZAKI, T
EICHELBAUM, M
HORAI, Y
HASHIMOTO, K
CHIBA, K
DENGLER, HJ
机构：
[1] YAMANASHI MED COLL,DEPT PHARMACOL,KOFU,JAPAN
[2] UNIV BONN,DEPT MED,D-5300 BONN,FED REP GER
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 23卷 / 04期
关键词：
D O I：
10.1111/j.1365-2125.1987.tb03080.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：482 / 485
页数：4
相关论文
共 16 条
[1]   PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].
BERTILSSON, L ;
DENGLER, HJ ;
EICHELBAUM, M ;
SCHULZ, HU .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155
[2]   GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].
CLARK, DWJ .
DRUGS, 1985, 29 (04) :342-375
[3]   INTER-ETHNIC DIFFERENCE IN SPARTEINE OXIDATION AMONG GHANAIANS AND GERMANS [J].
EICHELBAUM, M ;
WOOLHOUSE, NM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (01) :79-83
[4]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[5]   THE GENETIC-POLYMORPHISM OF SPARTEINE METABOLISM [J].
EICHELBAUM, M ;
REETZ, KP ;
SCHMIDT, EK ;
ZEKORN, C .
XENOBIOTICA, 1986, 16 (05) :465-481
[6]   POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J ;
ZEKORN, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186
[7]  
EICHELBAUM M, 1984, FED PROC, V43, P2298
[8]  
EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[9]  
IDLE JR, 1984, 2ND P WORLD C CLIN P, P148
[10]   DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE [J].
INABA, T ;
OTTON, SV ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :547-549
12